Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Jul;52(1):31–35. doi: 10.1038/bjc.1985.144

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.

M Dowsett, S J Santner, R J Santen, S L Jeffcoate, I E Smith
PMCID: PMC1977168  PMID: 4015950

Abstract

Aminoglutethimide without glucocorticoid has been shown to be a clinically effective treatment for postmenopausal breast cancer in low dosage (250 mg day-1). The mechanism of action of this approach is thought to be the inhibition of peripheral aromatase, the enzyme which converts androstenedione to oestrone. The activity of this enzyme was measured in vivo by injection with 3H-androstenedione and 14C-oestrone and found to be 0.20% +/- 0.05 in 5 patients on low dose AG therapy. In comparison with previously published data this demonstrates a 92% inhibition of peripheral aromatase activity confirming aromatase inhibition as a viable aim in the endocrine treatment of breast cancer.

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abul-Hajj Y. J. Inhibition of androgen aromatization in human breast cancer. J Steroid Biochem. 1980 Dec;13(12):1395–1400. doi: 10.1016/0022-4731(80)90049-7. [DOI] [PubMed] [Google Scholar]
  2. Cohen M. P. Aminoglutethimide inhibition of adrenal desmolase activity. Proc Soc Exp Biol Med. 1968 Apr;127(4):1086–1090. doi: 10.3181/00379727-127-32877. [DOI] [PubMed] [Google Scholar]
  3. Coombes R. C., Goss P., Dowsett M., Gazet J. C., Brodie A. 4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Lancet. 1984 Dec 1;2(8414):1237–1239. doi: 10.1016/s0140-6736(84)92795-8. [DOI] [PubMed] [Google Scholar]
  4. Dexter R. N., Fishman L. M., Ney R. L., Liddle G. W. Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab. 1967 Apr;27(4):473–480. doi: 10.1210/jcem-27-4-473. [DOI] [PubMed] [Google Scholar]
  5. Goldenberg I. S., Waters N., Ravdin R. S., Ansfield F. J., Segaloff A. Androgenic therapy for advanced breast cancer in women. A report of the cooperative breast cancer group. JAMA. 1973 Mar 12;223(11):1267–1268. [PubMed] [Google Scholar]
  6. Graves P. E., Salhanick H. A. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide. Endocrinology. 1979 Jul;105(1):52–57. doi: 10.1210/endo-105-1-52. [DOI] [PubMed] [Google Scholar]
  7. Harris A. L., Dowsett M., Smith I. E., Jeffcoate S. L. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. Br J Cancer. 1983 May;47(5):621–627. doi: 10.1038/bjc.1983.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris A. L., Powles T. J., Smith I. E. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3405s–3408s. [PubMed] [Google Scholar]
  9. Lipton A., Santen R. J. Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer. Cancer. 1974 Feb;33(2):503–512. doi: 10.1002/1097-0142(197402)33:2<503::aid-cncr2820330227>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  10. MacDonald P. C., Edman C. D., Hemsell D. L., Porter J. C., Siiteri P. K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol. 1978 Feb 15;130(4):448–455. doi: 10.1016/0002-9378(78)90287-9. [DOI] [PubMed] [Google Scholar]
  11. Miller W. R., Hawkins R. A., Forrest A. P. Significance of aromatase activity in human breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3365s–3368s. [PubMed] [Google Scholar]
  12. Poortman J., Thijssen J. H., Schwarz F. Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients. J Clin Endocrinol Metab. 1973 Jul;37(1):101–109. doi: 10.1210/jcem-37-1-101. [DOI] [PubMed] [Google Scholar]
  13. Samojlik E., Veldhuis J. D., Wells S. A., Santen R. J. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. J Clin Invest. 1980 Mar;65(3):602–612. doi: 10.1172/JCI109705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Santen R. J., Santner S., Davis B., Veldhuis J., Samojlik E., Ruby E. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab. 1978 Dec;47(6):1257–1265. doi: 10.1210/jcem-47-6-1257. [DOI] [PubMed] [Google Scholar]
  15. Santen R. J., Worgul T. J., Samojlik E., Interrante A., Boucher A. E., Lipton A., Harvey H. A., White D. S., Smart E., Cox C. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med. 1981 Sep 3;305(10):545–551. doi: 10.1056/NEJM198109033051003. [DOI] [PubMed] [Google Scholar]
  16. Smith I. E., Fitzharris B. M., McKinna J. A., Fahmy D. R., Nash A. G., Neville A. M., Gazet J. C., Ford H. T., Powles T. J. Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet. 1978 Sep 23;2(8091):646–649. doi: 10.1016/s0140-6736(78)92759-9. [DOI] [PubMed] [Google Scholar]
  17. Stuart-Harris R., Dowsett M., Bozek T., McKinna J. A., Gazet J. C., Jeffcoate S. L., Kurkure A., Carr L., Smith I. E. Low-dose aminoglutethimide in treatment of advanced breast cancer. Lancet. 1984 Sep 15;2(8403):604–607. doi: 10.1016/s0140-6736(84)90596-8. [DOI] [PubMed] [Google Scholar]
  18. Stuart-Harris R., Dowsett M., D'Souza A., Donaldson A., Harris A. L., Jeffcoate S. L., Smith I. E. Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. Clin Endocrinol (Oxf) 1985 Feb;22(2):219–226. doi: 10.1111/j.1365-2265.1985.tb01083.x. [DOI] [PubMed] [Google Scholar]
  19. Tilson-Mallett N., Santner S. J., Feil P. D., Santen R. J. Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab. 1983 Dec;57(6):1125–1128. doi: 10.1210/jcem-57-6-1125. [DOI] [PubMed] [Google Scholar]
  20. Wells S. A., Jr, Santen R. J., Lipton A., Haagensen D. E., Jr, Ruby E. J., Harvey H., Dilley W. G. Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Ann Surg. 1978 May;187(5):475–484. doi: 10.1097/00000658-197805000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES